wellrank.ai
Sign In
Nebido logo

Nebido

First cited by AI Jun 12, 2026
nebi.ba

Surfaced organically in AI answers about trt and men's health. Not yet profiled.

AI Visibility

Visibility trend

TRT and men's health, daily share of AI answers mentioning Nebido, through Sep 12, 2026.

4.4%

Avg position when mentioned: 4.5 · peak 9% on Aug 21

By engine

Where Nebido is strong, and where it is invisible.

  • ChatGPT
    13.3%

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 0 positive mentions
  • 44 neutral
  • 0 mixed or cautious

Recent AI answers mentioning Nebido

ChatGPTSep 10, 2026, 15:13 UTC
How much does TRT cost per month?

Short answer: it varies a lot. In the U.S. expect roughly $25–$2,000+ per month depending on the formulation, whether you use generic vs brand, and whether insurance covers it. Typical monthly cost ranges by formulation (approximate, out-of-pocket, U.S. retail prices): Generic injectable testosterone (cypionate or enanthate, self‑injected): $10–$60 for the medication. With supplies, lab monitoring and telemedicine/clinic fees plan you’ll commonly pay $50–$200/month total. Branded topical gels (AndroGel, Testim): $300–$700/month without insurance. Transdermal patch (Androderm): $300–$600/month. Nasal gel (Natesto): $300–$600/month. Long‑act­ing intramuscular undecanoate (Aveed/Nebido): large, infrequent injections — $800–$3,000 per injection; when spread across months this can be ~$200–$700/month. Subcutaneous pellets (Testopel): $300–$2,000 per insertion (lasts 3–6 months) → roughly $50–$650/month depending on insertion cost and frequency. Oral testosterone (Jatenzo): typically high — often $900–$2,000+/month. Other costs to factor: Initial evaluation and follow‑ups: $100–$300 per visit (varies by clinic; telemedicine can be cheaper). Lab testing (baseline and routine monitoring: total testosterone, free T, CBC, PSA, lipids, liver): $50–$300 per panel depending on insurer/discounts. Pharmacy markups, compounding pharmacy options, and mail‑order vs local pharmacy prices vary widely — use GoodRx or check insurance formularies. Insurance coverage: Many insurers will cover TRT if you meet diagnostic criteria (symptoms + documented low testosterone), but prior authorization and restrictions are common. Coverage dramatically reduces your out‑of‑pocket cost for branded products. Check with your insurer and provider. Services/brands you can consider (examples and why): Hims and Roman — telemedicine platforms that make evaluation, prescriptions, and home delivery simple; good for straightforward cases seeking convenience. Defy Medical and Vault Health — clinics/telehealth focused on men’s hormone care and ongoing monitoring; useful if you want more specialist oversight. Low T Center — in‑person clinics that commonly offer pellet therapy and quick access to treatment (variable quality; shop around). Local urologist or endocrinologist — recommended if you have complicated medical history, fertility concerns, or need specialist care. What I recommend doing next: Get baseline morning total testosterone and recommended labs (your PCP, urologist, or an online clinic can arrange this). Ask your insurer what they cover and whether prior authorization is required for specific brand names. Compare prices at local pharmacies, mail‑order, and telemedicine providers (use GoodRx or call pharmacies). If cost is the main concern, generic injectable testosterone is typically the lowest‑cost effective option. If you tell me: (a) which country you’re in and (b) whether you have insurance, I can give more specific cost estimates and suggest clinics or pharmacies to check.

Mentioned in position 6 of 14

Read full answer with sources →
ChatGPTSep 8, 2026, 15:21 UTC
How quickly does TRT work for energy and libido?

Short answer Many men notice increased libido within 1–3 weeks of starting TRT, with clearer improvement by 4–6 weeks. Energy and fatigue often improve a bit later: some benefit by 3–4 weeks, more noticeable by 6–12 weeks. Full sexual, mood and energy benefits commonly take 3–6 months and can continue to evolve after that. Why timing varies Baseline testosterone level, age, overall health, sleep, depression, medications, and whether erectile dysfunction has a vascular/neurologic cause all affect speed and degree of response. Route and dosing matter: injections often produce quicker rises in blood testosterone than daily gels; gels and long‑acting injections produce steadier levels. TRT improves sexual desire (libido) more reliably than erection quality; ED from blood‑flow problems may need additional treatments (PDE5 inhibitors). Typical timelines by symptom Libido (sexual desire): first signs 1–3 weeks; meaningful improvement by 4–6 weeks; many men reach good improvement by 3 months. Energy / fatigue: subtle changes in 3–4 weeks; clearer benefit by 6–12 weeks. Erectile function: often slower and less predictable — may take months and sometimes requires combination therapy (e.g., Viagra/Cialis). Mood, concentration, muscle mass, bone density: changes over months (3–12+ months). Route differences (practical note) Intramuscular injections (testosterone cypionate/enanthate like Depo‑Testosterone): rapid rises after injection; dosing weekly or every 1–2 weeks. Long‑acting injections (testosterone undecanoate like Aveed/Nebido): steadier levels over many weeks/months. Topical gels (AndroGel, Testim, Axiron, Fortesta): daily application, steady dosing; libido improvements often appear early once levels rise. Pellets (Testopel): slow steady release over months. Safety, monitoring, and important cautions Baseline tests before starting: morning total testosterone, CBC (hematocrit), PSA, CMP/liver tests, and often LH/FSH; consider sperm count if fertility matters. Recheck testosterone and hematocrit about 4–12 weeks after starting or dose change, then every 3–6 months initially. Common side effects: increased hematocrit, acne, fluid retention, decreased testicular size and sperm production, possible worsening of sleep apnea, and small risk signals for prostate issues. If you want children, TRT (exogenous testosterone) often suppresses sperm production — alternatives include clomiphene citrate or hCG to raise testosterone while preserving fertility. What you can do now Get morning (7–10 AM) total testosterone and relevant baseline labs. Discuss with a clinician whether TRT is appropriate and which form fits your goals/lifestyle. If erection problems persist, ask about adding a PDE5 inhibitor. Services/brands you might consider Depot/injectables: Depo‑Testosterone (testosterone cypionate) — widely used, flexible dosing. Aveed (testosterone undecanoate) / Nebido — long‑acting injections for less frequent dosing. Topicals: AndroGel, Testim, Axiron — daily gels with predictable absorption for many men. Pellets: Testopel — useful if you prefer infrequent procedures. Telemedicine/men’s health services: Vault Health (more comprehensive testing and follow‑up), Roman and Hims (convenient telemedicine and delivery). These can be good for access, but for complex cases or fertility concerns see an endocrinologist/urologist. When to see a specialist If you have a history of prostate cancer, known fertility desires, abnormal baseline labs, significant heart disease, or complex symptoms — see an endocrinologist or urologist experienced in male hormonal care. If you want, tell me: your age, recent morning testosterone level (if available), and whether you want children — I can give more tailored expectations and next steps.

Mentioned in position 3 of 11

Read full answer with sources →
ChatGPTAug 29, 2026, 15:53 UTC
How quickly does TRT work for energy and libido?

Short answer Libido (sex drive) often begins to improve within 1–3 weeks of starting TRT and commonly shows noticeable improvement by 4 weeks. Energy and overall fatigue usually improve a bit slower — many men feel better by 3–6 weeks, with more obvious change by 2–3 months. Erectile firmness/ability to get and maintain erections often takes longer than libido (4–12 weeks) and may need additional treatments (PDE‑5 inhibitors) if vascular/neurologic issues are present. Full benefits (mood, muscle, body composition, sexual function) are typically seen by 3–6 months. Why timelines vary Baseline testosterone level, age, how low you were, and overall health (sleep, thyroid, anemia, depression, diabetes, medications) affect response. Formulation matters: short-acting injectables (testosterone cypionate/enanthate) often produce faster and more noticeable effects than some gels because blood levels rise more quickly; gels produce steadier levels but still usually show benefits over weeks. Long‑acting depot injections or pellets can take several weeks to reach steady state. Dose, adherence, and how your body converts testosterone to estradiol (which can blunt benefit if high) also affect response. What to expect and when to check Week 1–4: libido and some mood/energy changes may begin. 4–12 weeks: clearer improvements in energy, libido, and erections for many men. 3–6 months: fuller effect on sexual function, mood, muscle, and body composition. Labs: check a baseline (morning) total testosterone, CBC, PSA, CMP, lipids; recheck testosterone and hematocrit at ~3 months after starting or dose change, then every 6–12 months. Also check estradiol if symptoms suggest imbalance. If you have fertility goals, TRT often suppresses sperm production — discuss alternatives (clomiphene citrate, hCG) before starting. When to follow up or change approach No meaningful improvement after ~12 weeks → re-evaluate dose/compliance, serum testosterone (am/steady), estradiol, other medical/psych causes. New side effects (breast enlargement/tenderness, leg swelling, shortness of breath, very red/ruddy face, hematocrit >54%) → contact your clinician promptly. Products and services (examples) Topical gels: AndroGel, Testim — widely used, easy daily dosing, good for steady levels but can transfer to others by skin contact. Injectables: Depo‑Testosterone (testosterone cypionate), Delatestryl (testosterone enanthate) — common intramuscular options that often produce faster symptomatic changes. Long‑acting option: Nebido (testosterone undecanoate) or Aveed (undecanoate in the US) — fewer injections but steadier long-term dosing (Nebido used more commonly outside the US). Pellets: Testopel — subcutaneous pellets that release testosterone over months. Fertility-sparing options: Clomiphene citrate (Clomid) or HCG injections are used when maintaining fertility is important. Telehealth/clinic options Defy Medical — specializes in hormone optimization and TRT with physician oversight and lab monitoring. Vault Health — focuses on men's health and testosterone programs with lab testing and clinician follow-up. Roman and Hims — convenient telehealth platforms that provide access to TRT and medications; good for accessibility but confirm their monitoring protocols meet your needs. For fertility concerns or complex cases, see a reproductive urologist or endocrinologist in person. Safety note TRT is a prescription treatment with potential risks (polycythemia, negative effects on fertility, changes in lipids, possible prostate effects). It should be started and monitored by a clinician with appropriate lab follow‑up. If you’d like, tell me: your current testosterone level, symptoms, age, whether you want to preserve fertility, and any medical conditions — I can give more tailored expectations and suggest which formulation or clinic type might fit you best.

Mentioned in position 5 of 12

Read full answer with sources →
ChatGPTAug 28, 2026, 21:35 UTC
Enclomiphene vs TRT: which should I consider first?

Short answer — if you want to preserve or improve fertility (or keep your own testes working), try an estrogen‑modulator that raises your own LH/FSH/testosterone (enclomiphene or the commonly used off‑label alternative clomiphene) first. If you do not want children, have primary testicular failure, or need rapid, predictable symptom control, then consider testosterone replacement therapy (TRT). Why (key points) Mechanism: Enclomiphene/clomiphene (SERM): raises GnRH→LH/FSH→increases your own testosterone production and usually preserves or improves sperm production. TRT: provides exogenous testosterone which relieves symptoms reliably but suppresses LH/FSH and usually reduces sperm production and shrinks testicular volume. Best candidates: Enclomiphene/clomiphene: younger men, men wanting to conceive, men with secondary hypogonadism (low T with low/normal LH/FSH). TRT: men with primary hypogonadism (high LH/FSH), older men who don’t want fertility, or men who need consistent symptom control. Reversibility & fertility: Enclomiphene/clomiphene: generally reversible and fertility‑friendly. TRT: can cause prolonged spermatogenesis suppression; may require hCG or stopping TRT to recover fertility (recovery can take months). Side effects/risks: Enclomiphene/clomiphene: mood changes, visual disturbances, nausea, possible estrogenic effects; not effective in all cases. TRT: increased hematocrit, acne, possible worsening of sleep apnea, potential cardiovascular considerations, prostate effects (need monitoring). Availability: Enclomiphene as a branded drug (Androxal) has limited availability/approval history in some regions; clomiphene citrate (Clomid) is widely available and commonly used off‑label in men. TRT options (examples): topical gels — AndroGel, Testim, Axiron; transdermal patch — Androderm; injectables — Depo‑Testosterone (testosterone cypionate), Delatestryl (enanthate), Aveed or Nebido (testosterone undecanoate); subcutaneous pellets — Testopel. What tests and monitoring you should get first Baseline morning total testosterone (repeat 2 measurements), free testosterone if indicated, LH, FSH, prolactin, SHBG. Baseline CBC (hematocrit), PSA (if older), lipid panel, and consider sleep apnea screening if symptomatic. Ongoing: symptom check and labs at ~6–12 weeks after starting therapy, then every 3–6 months initially for TRT (hematocrit, PSA, testosterone), less frequently once stable. Who to see / services Best: urologist specializing in male fertility or an endocrinologist experienced with male hypogonadism. Telemedicine/men’s health clinics that offer testing and treatment: Defy Medical (men’s health/endocrinology), Vault Health, Roman, Hims. If fertility is a priority, prioritize an in‑person urologist or reproductive endocrinologist. Practical recommendation Don’t start medication before getting morning labs (T, LH, FSH, prolactin) and discussing fertility desires. If labs show low T with low/normal LH → consider enclomiphene or clomiphene first (fertility‑friendly). If labs show low T with high LH (primary testicular failure) or you don’t want children → TRT is usually the appropriate first choice. If you start TRT but later want fertility, discuss adding hCG or stopping TRT and working with a specialist. If you’d like, tell me: your age, whether you want children, any lab results you already have, and what symptoms are most bothersome — I can help interpret labs or suggest the most appropriate next step and specific local or telemedicine options.

Mentioned in position 10 of 15

Read full answer with sources →
ChatGPTAug 23, 2026, 11:51 UTC
Enclomiphene vs TRT: which should I consider first?

Short answer If you want to preserve or improve fertility (or you have low/normal LH/FSH suggesting secondary hypogonadism), try a gonadotropin‑stimulating medicine first (enclomiphene if available, or more commonly clomiphene/Clomid off‑label). If you have primary testicular failure (high LH/FSH), severe symptoms that need rapid control, or fail a trial of a stimulator, then consider testosterone replacement therapy (TRT). Why (brief) Enclomiphene (the active enantiomer of clomiphene; marketed as Androxal in trials) and clomiphene (Clomid) raise endogenous LH/FSH → increase your own testosterone production and usually preserve or improve sperm production. Good choice when fertility matters or the problem is secondary (pituitary/hypothalamic). TRT (topical gels like AndroGel/Testim, injections like Depo‑Testosterone or testosterone undecanoate brands Aveed/Nebido) gives reliable, often faster symptom relief but suppresses LH/FSH and sperm production (worse for fertility) and requires ongoing monitoring for hematocrit, PSA, etc. Practical considerations Availability: Androxal (enclomiphene) has been limited commercially; clomiphene (Clomid) is widely available and commonly used off‑label for men. That makes clomiphene the realistic "stimulator" option for many. If your labs show high LH/FSH (primary hypogonadism) a stimulator likely won’t work — TRT is usually appropriate. If you plan children, avoid TRT unless you’ve discussed sperm preservation and alternatives with a specialist. Safety/monitoring (what your clinician will check) Baseline and follow‑up: morning total testosterone, free T (if indicated), LH, FSH, estradiol, prolactin, CBC (hematocrit), PSA, lipids, and liver tests as needed. Repeat testosterone and symptoms after ~8–12 weeks on a stimulator or TRT, then ongoing monitoring on TRT (every 3–6 months initially). TRT risks: erythrocytosis, possible PSA rise/prostate issues, decreased fertility. Clomiphene/enclomiphene risks: mood swings, visual disturbances, and less well‑defined long‑term safety data for enclomiphene; clomiphene has decades of off‑label male use. Where to go / services to consider Labs: Quest Diagnostics, LabCorp (for baseline and monitoring). Specialized clinics: Defy Medical (men’s hormone specialists with in‑depth endocrine/urology approach), local endocrinologist or urologist with men's health experience. Telemedicine/startup options: Roman or Hims can be convenient for starting TRT in straightforward cases, but if fertility, complex labs or abnormal results are an issue, prefer a specialist (Defy or a reproductive/urology clinic). If fertility is a concern, consult a reproductive urologist and consider sperm cryopreservation before TRT. Next steps (practical) Get morning labs (total testosterone, LH, FSH, estradiol, CBC, PSA). Review results with a specialist (endocrinologist or urologist experienced in male hormone disorders). If LH/FSH are low/normal and you want fertility, discuss trying clomiphene (Clomid) or enclomiphene (if available). If LH/FSH are high or you need rapid symptom control and are not concerned about fertility, discuss TRT options (AndroGel/Testim, Depo‑Testosterone, Aveed/Nebido) and monitoring. If you want, tell me any recent morning testosterone result and whether you want children — I can help interpret and suggest the next specific step.

Mentioned in position 7 of 12

Read full answer with sources →
ChatGPTAug 21, 2026, 11:58 UTC
What are the risks and side effects of starting TRT in your 30s?

Short answer Starting testosterone replacement therapy (TRT) in your 30s can help symptoms of clinically low testosterone, but it also carries important risks — especially for fertility and blood thickness. Many effects are reversible if caught early, but some (like impaired fertility) can be long-lasting. You should discuss risks, alternatives, and a monitoring plan with an endocrinologist or urologist before starting. Main risks and side effects Infertility and testicular atrophy: TRT suppresses LH/FSH → reduced sperm production and smaller testicles. This is the single biggest concern for men in their 30s who want biological children. Sperm production may recover after stopping TRT but can take many months and is not guaranteed. Polycythemia (increased hematocrit): TRT commonly raises red blood cell mass, which increases clot, stroke, and heart attack risk if hematocrit becomes high. Regular blood checks are essential. Cardiovascular effects: data are mixed. Some studies suggest increased cardiovascular risk in men with existing heart disease; other studies show neutral or beneficial effects. The risk-to-benefit ratio should be individualized. Mood and behavioral changes: can cause irritability, increased aggression, mood swings, or improvements in low mood — responses vary. Gynecomastia: increased conversion of testosterone to estradiol can cause breast tissue enlargement. Acne and oily skin, and possible acceleration of male-pattern hair loss. Worsening or unmasking of obstructive sleep apnea. Prostate effects: TRT can raise PSA levels; TRT is contraindicated if you have known prostate cancer. Baseline prostate evaluation is needed. Liver effects: oral 17‑alpha-alkylated androgens (rarely used for TRT) can damage the liver. Injectable and transdermal products are much less hepatotoxic. Venous thromboembolism: higher hematocrit increases thrombotic risk; rare reports of VTE exist. Injection- or application-site reactions, or transfer of topical gels to partners/children if precautions aren’t used. Alternatives and fertility-preserving options If you want to preserve fertility, consider: Clomiphene citrate (Clomid) — a SERM that stimulates your own testosterone production without the same suppressive effect on sperm in many men. Human chorionic gonadotropin (hCG; brands include Pregnyl, Ovidrel, Novarel) — preserves intratesticular testosterone and sperm production; often used alone or with TRT. Aromatase inhibitors (less commonly used) in selected cases. Consider sperm banking (cryopreservation) before starting TRT if you might want children later. Monitoring and baseline testing (typical plan) Baseline: total testosterone (morning, two separate measurements ideally), LH, FSH, prolactin if indicated, free testosterone or SHBG if needed, hematocrit/hemoglobin, lipid profile, fasting glucose/HbA1c, LFTs, PSA and prostate exam as appropriate. After starting or changing dose: check testosterone and hematocrit at ~3 months; hematocrit rechecked at 3 and 6 months and then at least yearly. Check PSA and symptoms periodically (usually 3–6 months then yearly) and other labs as indicated. Adjust dose or stop if hematocrit >54% (thresholds vary), if PSA rises significantly, or if unacceptable side effects occur. Practical points about formulations (examples) Transdermal gels: AndroGel, Testim — easy daily dosing, steady levels; risk of transfer to others. Transdermal patch: Androderm — steady delivery; skin irritation is common. Nasal gel: Natesto — multiple daily doses, lower transfer risk. Short-acting intramuscular injections: Testosterone cypionate (Depo-Testosterone) — inexpensive, flexible dosing, more peaks/troughs depending on schedule. Long-acting injectable: Testosterone undecanoate (Nebido internationally, Aveed in the US) — injections less frequent (weeks to months); Aveed requires in-office administration and has specific safety considerations. Subcutaneous pellets (e.g., Testopel) — last months but require procedure and have different removal/complication risks. Note: choice of formulation affects convenience, cost, side-effect profile (e.g., transfer risk, liver risk), and blood-level stability. Recommended next steps See a specialist (endocrinologist or urologist with men’s health experience) for full evaluation. If you may want children, consider sperm banking and ask about fertility-preserving regimens (clomiphene, hCG). Get baseline labs listed above and create a monitoring schedule. Discuss formulation options, risks specific to your health (cardiac disease, sleep apnea, prostate history), and written informed consent about fertility effects. Specific services and brands to consider TRT products: AndroGel, Testim (gels) — commonly used and easy to dose; Depo-Testosterone (testosterone cypionate) — commonly used injectable and cost-effective; Nebido (testosterone undecanoate) or Aveed — long-acting injectables if you prefer less frequent dosing; Natesto (nasal) if you want lower transfer risk. Fertility preservation: California Cryobank and Cryobank America — large, reputable sperm-banking services with many U.S. locations. Labs and monitoring: LabCorp and Quest Diagnostics — widely available for the blood tests listed. Clinical resources: seek care at a men’s health clinic or from specialists at centers such as Mayo Clinic or Cleveland Clinic if you want a multidisciplinary evaluation. If you want, tell me: whether you plan to have children, any personal or family history of heart disease, blood clots, prostate cancer, or sleep apnea, and I can outline a personalized checklist of tests and questions to bring to your doctor.

Mentioned in position 6 of 12

Read full answer with sources →

TL;DR

Nebido is a long-acting injectable testosterone undecanoate indicated for testosterone replacement therapy in men with hypogonadism, manufactured by Bayer and marketed under the domain nebi.ba. The product is well established in clinical practice outside North America and surfaces occasionally in AI-generated answers about TRT and men's health. According to WellRank's index, Nebido currently ranks tenth in its category with 8% AI answer visibility, and both recorded AI mentions carry a neutral tone.

Company Overview

Nebido is a branded prescription medicine developed and marketed by Bayer, a global pharmaceutical company headquartered in Leverkusen, Germany. The product is positioned as a depot injection given at extended intervals, reducing the burden of frequent dosing compared with shorter-acting testosterone preparations. Bayer distributes Nebido across numerous international markets, though its availability and regulatory status vary by country.

Product Features

  • Testosterone undecanoate 1000 mg per 4 mL ampoule formulated in castor oil for intramuscular injection
  • Extended dosing interval of approximately 10 to 14 weeks after an initial loading period
  • Designed to maintain stable serum testosterone levels between injections
  • Prescription-only depot injection administered by a healthcare professional
  • Indicated specifically for hypogonadism in adult men with confirmed testosterone deficiency

Target Market

Nebido is intended for adult men diagnosed with hypogonadism, a condition involving insufficient endogenous testosterone production. It is primarily prescribed in European, Middle Eastern, and other international markets where it holds regulatory approval, and it is not approved by the FDA for use in the United States. Prescribers are typically endocrinologists, urologists, and general practitioners managing men's hormonal health.

Buyer Personas

  • A middle-aged man with clinically confirmed hypogonadism who prefers infrequent clinic visits over daily topical application or self-injection.
  • An endocrinologist or urologist seeking a long-acting testosterone depot that reduces patient adherence concerns.
  • A general practitioner in a market where Nebido is a first-line formulary option for TRT, looking for a well-documented branded injectable.
  • A patient who has experienced skin-transfer concerns with gels and is transitioning to an injectable alternative under specialist guidance.

Funding & Performance

Nebido is a product line within Bayer AG, a publicly listed global pharmaceutical and life-sciences corporation traded on the Frankfurt Stock Exchange. Specific revenue figures attributable to Nebido alone are not publicly disclosed as a separate line item in Bayer's financial reporting.

Recent Developments

Bayer has continued to maintain Nebido's presence across established international markets, and the product remains one of the most widely studied long-acting injectable testosterone formulations in clinical literature. No major reformulation or new indication has been widely reported in recent periods. Regulatory discussions about testosterone therapies broadly are ongoing in various jurisdictions, which may affect market access over time.

Competitive Landscape

In AI-generated answers about TRT and men's health, Nebido is mentioned alongside products including Testim, Depo-Testosterone, Aveed, Androderm, AndroGel, Testopel, and the telehealth platform Roman, according to WellRank co-mention data. Its closest clinical competitors are other injectable testosterone preparations such as Aveed and Depo-Testosterone, as well as topical options like AndroGel and Androderm that dominate the US market where Nebido is not approved. The presence of Roman in this co-mention cluster reflects broader AI association between prescription TRT products and direct-to-consumer men's health platforms.

Nebido vs the brands AI recommends alongside it

The real competitive set in TRT and men's health: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
Nebido logo
NebidoThis brand
#37
4.4%
AndroGel logo
AndroGel

43 shared answers

#11
15.6%
Testim logo
Testim

42 shared answers

#20
11.1%
Aveed logo
Aveed

35 shared answers

#25
6.7%
Depo-Testosterone logo
Depo-Testosterone

33 shared answers

#36
4.4%

Email me when overtakes Nebido

One email the day the ranks flip. Nothing else.

User Sentiment

WellRank's corpus records two AI mentions of Nebido, both neutral in tone, with no positive or cautious signals detected. This neutral framing is consistent with how AI engines tend to treat established prescription medications, describing indications and administration without strong evaluative language. Public patient discussion, where it exists, generally centers on injection frequency convenience and tolerability of the oil-based formulation, though no aggregated sentiment data is publicly available.

Pricing

Pricing for Nebido varies by country, healthcare system, and whether it is reimbursed under national or private insurance schemes. Exact out-of-pocket or list prices are not published centrally and differ substantially across the international markets where the product is sold.

Sources cited around Nebido

The sites engines cite in answers mentioning this brand. Win these, win the answer.

    Track Nebido weekly

    One email a week: rank moves, new competitors, and the answers that changed. No noise.

    Work at Nebido? Get your AI Visibility Audit.

    See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.